Supreme Court Faces Choice On Pay-for-Delay Cases

Washington Drug Letter
The FTC has asked the Supreme Court to take up and overturn an 11th Circuit Court’s decision that upheld the legality of reverse patent settlements between branded drug makers and generic competitors.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00